TABLE 2

Distributions of SUVmax and Ki-67 Across Different Time Points

Time pointAimParameter testedpCR statusNo. of evaluable participantsRangeMeanSDP*
Baseline (FLT1)Primary aimSUVmaxAll data510.87–11.765.652.970.62
pCR91.86–11.766.093.17
no-pCR420.87–11.685.552.95
After 1 cycle of NAC (FLT2)Primary aimSUVmaxAll data510.44–8.293.211.840.35
pCR90.92–8.293.002.54
No-pCR420.44–6.433.251.69
After completion of NAC (FLT3)FLT3 secondary aimSUVmaxAll data430.33–7.461.741.810.0047
pCR80.37–1.080.620.27
No-pCR350.33–7.462.001.92
Ki-67 secondary aimKi-67All data430–738184.14220.16<0.001
pCR80–00.000.00
No-pCR350–738226.23223.77
  • * 2-sided exact P value from Wilcoxon 2-sample test.